Introduction:

cancer is the second leading cause of death in the world; the tumors of the digestive system occupy the second place and according to itslocation, those in the pancreas have the lowest survival rate.

Objective:

to assess the effectiveness of multidimensional analgesia for patients in terminal stage due to pancreatic cancer.

Methods:

a quasi-experimental, comparative, prospective and longitudinal study was conducted in patients with pain due to pancreatic tumor in terminal stage at Abel Santamaria Cuadrado General Teaching Hospital from November 2016 to July 2019; all patients with pain due topancreatictumor were included. In the terminal stage of pancreatic cancer, three (3) groups were completed according to the analgesia method applied; Group I (n = 10) multimodal analgesia, Group II (n = 10) multidimensional analgesia and Group III (n = 3) following WHO analgesia scheme, analgesia quality, and the need for rescue dose and application of morphine, the methods were compared and survival rate was determined.

Results:

the quality of analgesia was higher in patients from group II, in the same group the application of morphine was not required until the 7th month and in only two patients (p = 0.00), there were no differences in the rates of survival.

Conclusions:

the multidimensional approach to analgesia, where the individual is included as a biopsychosocial being and the family achieves greater quality of analgesia, the method applied for pain relief does not influence on survival.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )